French pharmaceutical giant Sanofi has officially announced the discontinuation of a late-stage clinical trial evaluating its experimental anti-inflammatory molecule, riliprubart.... Read more
Category: Uncategorized
FDA clears every-8-week lebrikizumab maintenance dosing for Eli Lilly’s atopic dermatitis biologic
The U.S. Food and Drug Administration (FDA) has officially approved an extended every-8-week (Q8W) maintenance dosing regimen for Eli Lilly... Read more
Genentech and Novartis sponsor microdrama series to elevate food allergy awareness
Biopharmaceutical leaders Genentech and Novartis have co-sponsored a novel four-part digital microdrama series tracking the daily lives of young adults... Read more
Teva to lay off 250 at API unit as divestiture of TAPI business drags on
Teva Pharmaceuticals plans to eliminate 250 jobs within its contract development and manufacturing organization (CDMO) unit over the next two... Read more
Vietnam establishes 3 macro policy pillars to control full-spectrum food safety value chains
According to official dispatches from the Vietnam Food Administration (Ministry of Health), the government is aggressively mobilizing a strategic overhaul... Read more
Vietnam Ministry of Health decentralizes advertising approvals for dietary supplements to provincial authorities starting July 1
The Deputy Minister of Health, Do Xuan Tuyen, has officially signed and enacted Decision No. 1644/QD-BYT, promulgating 3 amended and... Read more
Surging cases and high-risk serotypes: Medical experts warn of unpredictable Dengue patterns in Vietnam
The Sức khỏe & Đời sống (Health & Life) Newspaper, in collaboration with Takeda Pharmaceuticals Vietnam Co., Ltd. and the... Read more
UK scientists launch first human trial of broad-spectrum vaccine engineered by AI
Scientists at the University of Cambridge have achieved a landmark milestone in global medicine by initiating the first human clinical... Read more
AlzeCure enters potential $1 billion global out-licensing pact with Eli Lilly for Alzheimer’s drug
Swedish biotech AlzeCure Pharma has announced that it has entered into a definitive collaboration and global out-licensing agreement with Eli... Read more








